10 Aug 2022 , 01:53 PM
Net profit of Ipca Laboratories declined 53.35% to Rs 143.06 crore in the quarter ended June 2022 as against Rs 306.66 crore during the previous quarter ended June 2021. Sales rose 1.27% to Rs 1585.74 crore in the quarter ended June 2022 as against Rs 1565.79 crore during the previous quarter ended June 2021.
| Particulars | Quarter Ended | ||
| ? | Jun. 2022 | Jun. 2021 | % Var. |
| Sales | 1585.74 | 1565.79 | 1 |
| OPM % | 16.78 | 26.45 | – |
| PBDT | 281.21 | 433.31 | -35 |
| PBT | 219.50 | 377.44 | -42 |
| NP | 143.06 | 306.66 | -53 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
